Search

Your search keyword '"Illicit Drugs economics"' showing total 311 results

Search Constraints

Start Over You searched for: Descriptor "Illicit Drugs economics" Remove constraint Descriptor: "Illicit Drugs economics"
311 results on '"Illicit Drugs economics"'

Search Results

1. Analyzing the geographic influence of financial inclusion on illicit drug use in Nigeria.

2. An ecological study of the correlation between COVID-19 support payments and overdose events in British Columbia, Canada.

3. Individual differences in legal and illicit cannabis purchasing behaviour in British Columbia, Canada: Findings from a 2021 cross-sectional survey.

4. What's in Stock? Drug drought anticipation during COVID-19 among people who use drugs and service providers.

5. Availability of substances for use in personal vaporisers on three online cryptomarkets.

6. Ecological momentary assessment of daily drug use and harm reduction service utilization among people who inject drugs in non-urban areas: A concurrent mixed-method feasibility study.

7. Synthetic cathinones - From natural plant stimulant to new drug of abuse.

8. Availability, retail price and potency of legal and illegal cannabis in Canada after recreational cannabis legalisation.

9. An evidence synthesis of strategies, enablers and barriers for keeping secrets online regarding the procurement and supply of illicit drugs.

10. Using recreational cannabis to treat insomnia: Evidence from over-the-counter sleep aid sales in Colorado.

11. Should we smoke it for you as well? An ethnographic analysis of a drug cryptomarket environment.

12. Illicit fentanyls in the opioid street market: desired or imposed?

13. Availability of legalized cannabis reduces demand for illegal cannabis among Canadian cannabis users: evidence from a behavioural economic substitution paradigm.

14. Retail price and availability of illicit cannabis in Canada.

15. Violent drug cartels stifle Mexican science.

17. Price elasticity of illegal versus legal cannabis: a behavioral economic substitutability analysis.

18. Scoring the best deal: Quantity discounts and street price variation of diverted oxycodone and oxymorphone.

19. Crime displacement in digital drug markets.

20. Informal recycling, income generation and risk: Health and social harms among people who use drugs.

21. Systematic review of guidelines in estimating social costs on drugs.

22. An altered state? Emergent changes to illicit drug markets and distribution networks in scotland.

23. Forensic drug intelligence and the rise of cryptomarkets. Part II: Combination of data from the physical and virtual markets.

24. Drug supply indicators: Pitfalls and possibilities for improvements to assist comparative analysis.

25. We Can't Go Cold Turkey: Why Suppressing Drug Markets Endangers Society.

26. Comparing cryptomarkets for drugs. A characterisation of sellers and buyers over time.

27. Drug affordability-potential tool for comparing illicit drug markets.

28. Offline constraints in online drug marketplaces: An exploratory analysis of a cryptomarket trade network.

29. Illegal drug use and its correlates in San Juan, Puerto Rico.

30. "Now drugs in Libya are much cheaper than food": A qualitative study on substance use among young Libyans in post-revolution Tripoli, Libya.

31. An island apart? Risks and prices in the Australian cryptomarket drug trade.

32. The social cost of drugs in France in 2010.

33. Social costs of illegal drugs, alcohol and tobacco in the European Union: A systematic review.

35. Silicon to syringe: Cryptomarkets and disruptive innovation in opioid supply chains.

36. Online test purchased new psychoactive substances in 5 different European countries: A snapshot study of chemical composition and price.

37. Economic consequences of legal and illegal drugs: The case of social costs in Belgium.

38. The social cost of illicit drugs use in Spain.

39. An insight into the deep web; why it matters for addiction psychiatry?

40. A market on both "sides" of the law: The use of the hidden web for the sale of new psychoactive substances.

41. New psychoactive substances: Purchasing and supply patterns in Australia.

42. From concept(ion) to life after death/the grave: The 'natural' history and life cycle(s) of novel psychoactive substances (NPS).

43. Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands.

44. Research as due diligence: What can supply-side interventions accomplish and at what cost?

45. A Structural Model of the Retail Market for Illicit Drugs.

46. Delivery dilemmas: How drug cryptomarket users identify and seek to reduce their risk of detection by law enforcement.

47. Disruptive Potential of the Internet to Transform Illicit Drug Markets and Impact on Future Patterns of Drug Consumption.

48. Social suppliers: Exploring the cultural contours of the performance and image enhancing drug (PIED) market among bodybuilders in the Netherlands and Belgium.

49. Deconstructing Designer Drugs.

50. Drugs, Violence, and Trauma in Mexico and the USA.

Catalog

Books, media, physical & digital resources